Yang Shuofei, Qi Haozhe, Kan Kejia, Chen Jiaquan, Xie Hui, Guo Xiangjiang, Zhang Lan
Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Shock. 2017 Feb;47(2):132-139. doi: 10.1097/SHK.0000000000000741.
Patients with sepsis commonly exhibit a hypercoagulability with high risk of venous thromboembolism (VTE). Neutrophil extracellular traps (NETs) are found to trigger inflammation and coagulation. We aim to determine whether NETs promoted the hypercoagulability and early anticoagulation reduced NETs releasing during sepsis.
In this prospective study, septic patients between September 2013 and June 2015 were included. Patients of age <18 years, acute organ failure, pregnancy, coagulation disorders, receiving anticoagulation before admission were excluded. Blood was sampled in 52 sepsis and 10 non-sepsis patients and 40 healthy controls, clinical, and hematological parameters were collected. The ability of plasma and platelets to prime neutrophils to release NETs and contribution of NETs to coagulation were assessed. NETs releasing was compared in patients with or without early coagulation, and its correlation with the risk of VTE was also evaluated.
NETs formation in septic patients was significantly higher than controls and non-sepsis patients. Neutrophils from septic patients had significantly enhanced NETs releasing compared with those from controls or non-sepsis patients. Plasma or platelets obtained from patients induced control neutrophils to release NETs. Notably, NETs released by neutrophils from septic patients significantly increased the potency of control plasma to generate thrombin and fibrin, and this effect was attenuated by administration of DNase I. Post-treatment NETs releasing in septic patients receiving early anticoagulation within 6 h was significantly lower than patients without early anticoagulation. The NETs formation correlated positively with the VTE risk, rather than the parameters of inflammation or disease severity.
The systemic inflammation during sepsis primes neutrophils to release NETs with increased risk of VTE. Early anticoagulation (6 h) reduces NETs releasing and may improve the coagulopathy of septic patients.
脓毒症患者通常表现出高凝状态,静脉血栓栓塞(VTE)风险高。发现中性粒细胞胞外陷阱(NETs)可引发炎症和凝血。我们旨在确定NETs是否促进脓毒症期间的高凝状态以及早期抗凝是否可减少NETs释放。
在这项前瞻性研究中,纳入了2013年9月至2015年6月期间的脓毒症患者。排除年龄<18岁、急性器官衰竭、妊娠、凝血障碍、入院前接受抗凝治疗的患者。采集了52例脓毒症患者、10例非脓毒症患者和40例健康对照者的血液,收集了临床和血液学参数。评估血浆和血小板促使中性粒细胞释放NETs的能力以及NETs对凝血的作用。比较了有或无早期凝血的患者的NETs释放情况,并评估了其与VTE风险的相关性。
脓毒症患者的NETs形成明显高于对照组和非脓毒症患者。与对照组或非脓毒症患者相比,脓毒症患者的中性粒细胞NETs释放明显增强。从患者获得的血浆或血小板可诱导对照中性粒细胞释放NETs。值得注意的是,脓毒症患者中性粒细胞释放的NETs显著增加了对照血浆产生凝血酶和纤维蛋白的能力,而这种作用可通过给予DNase I而减弱。在6小时内接受早期抗凝治疗的脓毒症患者治疗后的NETs释放明显低于未接受早期抗凝治疗的患者。NETs形成与VTE风险呈正相关,而非与炎症或疾病严重程度参数相关。
脓毒症期间的全身炎症促使中性粒细胞释放NETs,增加了VTE风险。早期抗凝(6小时)可减少NETs释放,并可能改善脓毒症患者的凝血病。